FusionPharm, Inc.
FSPM
$0.0001
$0.000.00%
| 03/31/2012 | 09/30/2011 | 03/31/2011 | |||
|---|---|---|---|---|---|
| Revenue | 71.80K | 131.90K | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 71.80K | 131.90K | -- | ||
| Cost of Revenue | 39.00K | 56.20K | -- | ||
| Gross Profit | 32.80K | 75.70K | -- | ||
| SG&A Expenses | 114.40K | 120.60K | 12.80K | ||
| Depreciation & Amortization | 7.60K | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 160.90K | 176.80K | 12.80K | ||
| Operating Income | -89.10K | -44.90K | -12.80K | ||
| Income Before Tax | -89.10K | -44.90K | -12.80K | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -89.10K | -44.90K | -12.80K | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -89.10K | -44.90K | -12.80K | ||
| EBIT | -89.10K | -44.90K | -12.80K | ||
| EBITDA | -81.50K | -- | -- | ||
| EPS Basic | -0.04 | -0.02 | -0.01 | ||
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | ||
| EPS Diluted | -0.04 | -0.02 | -0.01 | ||
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | ||
| Average Basic Shares Outstanding | 2.25M | 2.12M | 860.00K | ||
| Average Diluted Shares Outstanding | 2.25M | 2.12M | 860.00K | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||
